174 related articles for article (PubMed ID: 34669274)
1. Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report.
García JP; Hoyos JA; Alzate JA; Cristancho E
Biomedica; 2021 Oct; 41(Sp. 2):13-20. PubMed ID: 34669274
[TBL] [Abstract][Full Text] [Related]
2. Bacillus Clausii Septicemia in a Pediatric Patient After Treatment With Probiotics.
Joshi S; Udani S; Sen S; Kirolikar S; Shetty A
Pediatr Infect Dis J; 2019 Sep; 38(9):e228-e230. PubMed ID: 31033906
[TBL] [Abstract][Full Text] [Related]
3.
Ianiro G; Rizzatti G; Plomer M; Lopetuso L; Scaldaferri F; Franceschi F; Cammarota G; Gasbarrini A
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30103531
[TBL] [Abstract][Full Text] [Related]
4. Content Analysis of Commercially Available Probiotics.
Yadav P; Sharma P; Arora R
Indian Pediatr; 2018 Apr; 55(4):344-345. PubMed ID: 29428923
[TBL] [Abstract][Full Text] [Related]
5. Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
Altcheh J; Carosella MV; Ceballos A; D'Andrea U; Jofre SM; Marotta C; Mugeri D; Sabbaj L; Soto A; Josse C; Montestruc F; McFarland LV
Medicine (Baltimore); 2022 Sep; 101(36):e30500. PubMed ID: 36086703
[TBL] [Abstract][Full Text] [Related]
6. Promising clinical and immunological efficacy of Bacillus clausii spore probiotics for supportive treatment of persistent diarrhea in children.
Dang HT; Tran DM; Phung TTB; Bui ATP; Vu YH; Luong MT; Nguyen HM; Trinh HT; Nguyen TT; Nguyen AH; Van Nguyen AT
Sci Rep; 2024 Mar; 14(1):6422. PubMed ID: 38494525
[TBL] [Abstract][Full Text] [Related]
7. Bacillus clausii UBBC-07 reduces severity of diarrhoea in children under 5 years of age: a double blind placebo controlled study.
Sudha MR; Jayanthi N; Pandey DC; Verma AK
Benef Microbes; 2019 Mar; 10(2):149-154. PubMed ID: 30638396
[TBL] [Abstract][Full Text] [Related]
8. Septicemia due to Bacillus clausii after the use of probiotics. A complication to keep in mind.
Muñoz M; Castaño G E; Esquivel Suman R; Alvarado M
Andes Pediatr; 2023 Jun; 94(3):379-385. PubMed ID: 37909941
[TBL] [Abstract][Full Text] [Related]
9. Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.
Ripert G; Racedo SM; Elie AM; Jacquot C; Bressollier P; Urdaci MC
Antimicrob Agents Chemother; 2016 Jun; 60(6):3445-54. PubMed ID: 27001810
[TBL] [Abstract][Full Text] [Related]
10.
Erbaş İC; Nişancı B; Gür B; Makay BB; İnce OT; Belet N
Clin Pediatr (Phila); 2024 Feb; 63(2):183-186. PubMed ID: 37850558
[No Abstract] [Full Text] [Related]
11. Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores.
Kharwar A; Bazaz MR; Dandekar MP
BMC Microbiol; 2022 Sep; 22(1):217. PubMed ID: 36114449
[TBL] [Abstract][Full Text] [Related]
12. Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study.
Clerc O; Prod'hom G; Vogne C; Bizzini A; Calandra T; Greub G
Clin Infect Dis; 2013 Apr; 56(8):1101-7. PubMed ID: 23264363
[TBL] [Abstract][Full Text] [Related]
13. Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina
Khatri I; Sharma G; Subramanian S
BMC Microbiol; 2019 Dec; 19(1):307. PubMed ID: 31888501
[TBL] [Abstract][Full Text] [Related]
14. Bio-removal of tetracycline antibiotics under the consortium with probiotics Bacillus clausii T and Bacillus amyloliquefaciens producing biosurfactants.
Liu CX; Xu QM; Yu SC; Cheng JS; Yuan YJ
Sci Total Environ; 2020 Mar; 710():136329. PubMed ID: 31918182
[TBL] [Abstract][Full Text] [Related]
15. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review.
Acosta-Rodríguez-Bueno CP; Abreu Y Abreu AT; Guarner F; Guno MJV; Pehlivanoğlu E; Perez M
Adv Ther; 2022 Nov; 39(11):4854-4874. PubMed ID: 36018495
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in patients with multidrug-resistant bacteremia: a single-center study in Korea.
Mok J; Jo EJ; Eom JS; Kim MH; Kim KU; Park HK; Lee MK; Lee K
Korean J Intern Med; 2019 Sep; 34(5):1058-1067. PubMed ID: 31072077
[TBL] [Abstract][Full Text] [Related]
17. Bacillus clausii Bacteremia Following Probiotic Use: A Report of Two Cases.
Corredor-Rengifo D; Tello-Cajiao ME; García-Molina FA; Montero-Riascos LF; Segura-Cheng JD
Cureus; 2024 Apr; 16(4):e57853. PubMed ID: 38721227
[TBL] [Abstract][Full Text] [Related]
18. Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.
Paparo L; Tripodi L; Bruno C; Pisapia L; Damiano C; Pastore L; Berni Canani R
Sci Rep; 2020 Jul; 10(1):12636. PubMed ID: 32724066
[TBL] [Abstract][Full Text] [Related]
19.
de Castro JA; Guno MJV; Perez MO
Trop Dis Travel Med Vaccines; 2019; 5():14. PubMed ID: 31367461
[TBL] [Abstract][Full Text] [Related]
20. Early adjustment of empirical antibiotic therapy of bloodstream infections on the basis of direct identification of bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and Gram staining results.
Torres I; Pinto C; Oltra R; Pascual T; Carbonell N; Colomina J; Tormo M; Albert E; Aguilar G; Solano C; Navarro D
J Infect Chemother; 2020 Sep; 26(9):963-969. PubMed ID: 32386929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
